TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 24 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64 | -27.3% | 135,710 | +0.1% | 0.00% | – |
| Q2 2023 | $88 | -21.4% | 135,610 | +0.1% | 0.00% | – |
| Q1 2023 | $112 | +6.7% | 135,410 | +0.7% | 0.00% | – |
| Q4 2022 | $105 | -99.9% | 134,410 | -7.1% | 0.00% | – |
| Q3 2022 | $156,000 | +15.6% | 144,710 | -39.9% | 0.00% | – |
| Q2 2022 | $135,000 | +285.7% | 240,710 | +559.3% | 0.00% | – |
| Q1 2022 | $35,000 | +75.0% | 36,510 | +87.1% | 0.00% | – |
| Q4 2021 | $20,000 | -16.7% | 19,510 | +50.1% | 0.00% | – |
| Q3 2021 | $24,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| tru Independence LLC | 3,500 | $11,515,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 7,972 | $26,000 | 0.00% |
| Westside Investment Management, Inc. | 8 | $0 | 0.00% |
| American Portfolios Advisors | 23 | $76 | 0.00% |
| ROYAL BANK OF CANADA | 1 | $0 | 0.00% |
| VANGUARD GROUP INC | 56,691 | $186,000 | 0.00% |
| Advisory Services Network, LLC | 2,000 | $7,000 | 0.00% |
| UBS Group AG | 6,062 | $20,000 | 0.00% |
| Sowell Financial Services LLC | 19 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 15 | $0 | 0.00% |